Physician profile
Boris Ackerman
NPI 1295829802
$1,778.18
in general payments reported to CMS, 2019-2025
12 companies · $34.04 in 2025
The $34.04 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $162 · 2021: $219 · 2022: $550 · 2023: $181 · 2024: $369 · 2025: $34.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $378.93 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $276.77 | 2019-2022 | |
| Sientra, INC. | $171.16 | 2022 | |
| Polynovo North America LLC | $164.56 | 2024 | Novosorb Btm |
| Kerecis Limited | $144.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $131.04 | 2022 | |
| Abbvie INC. | $127.32 | 2023-2025 | Botox |
| Biom'Up Sa | $122.87 | 2019 | |
| Innovation Technologies INC | $118.89 | 2020 | |
| Baxter Healthcare | $106.26 | 2021-2022 | |
| Biosense Webster, INC. | $21.38 | 2021 | |
| Galderma Laboratories, L.P. | $14.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.